Treating More with Less: Effectiveness and Event Outcomes of Antituberculosis Fixed-dose Combination Drug versus Separate-drug Formulation (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) for Pulmonary Tuberculosis Patients in Real-world Clinical Practice

INTRODUCTION: Conventionally, a combination of four separate drugs (ethambutol, isoniazid, rifampicin, and pyrazinamide [EHRZ]) is the first-line pharmacotherapy for pulmonary tuberculosis (TB). In recent years, fixed-dose combination (FDC) formulation, where a single tablet contains the active ingr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Jacqueline Mui Lan, Yang, Su Lan, Avoi, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380106/
https://www.ncbi.nlm.nih.gov/pubmed/30814828
http://dx.doi.org/10.4103/jgid.jgid_50_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380106/
https://www.ncbi.nlm.nih.gov/pubmed/30814828
http://dx.doi.org/10.4103/jgid.jgid_50_18

Ejemplares similares